Sino Biopharmaceutical (OTCMKTS:SBMFF) Reaches New 52-Week Low at $0.31

Shares of Sino Biopharmaceutical Limited (OTCMKTS:SBMFFGet Free Report) reached a new 52-week low during trading on Friday . The company traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares trading hands. The stock had previously closed at $0.31.

Sino Biopharmaceutical Price Performance

The stock has a 50 day moving average of $0.36 and a 200 day moving average of $0.39.

About Sino Biopharmaceutical

(Get Free Report)

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines comprising Qingkeshu tablets, Focus V capsules, Annike injection, and Anyue capsules; liver disease medicines, including Tianqing ganmei injection and Runzhong dispersible tablets; and respiratory system medicines, such as Tianqing suchang suspension for inhalation and Tianyun for injection.

Featured Stories

Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.